Ming‐Fen Ho

459 total citations
32 papers, 325 citations indexed

About

Ming‐Fen Ho is a scholar working on Molecular Biology, Biological Psychiatry and Genetics. According to data from OpenAlex, Ming‐Fen Ho has authored 32 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Biological Psychiatry and 7 papers in Genetics. Recurrent topics in Ming‐Fen Ho's work include Tryptophan and brain disorders (7 papers), Alcohol Consumption and Health Effects (5 papers) and Substance Abuse Treatment and Outcomes (4 papers). Ming‐Fen Ho is often cited by papers focused on Tryptophan and brain disorders (7 papers), Alcohol Consumption and Health Effects (5 papers) and Substance Abuse Treatment and Outcomes (4 papers). Ming‐Fen Ho collaborates with scholars based in United States, Japan and Australia. Ming‐Fen Ho's co-authors include Richard M. Weinshilboum, Liewei Wang, Hu Li, Roselyn B. Rose’Meyer, Lingxin Zhang, James N. Ingle, Irene Moon, Joanna M. Biernacka, Krishna R. Kalari and Cheng Zhang and has published in prestigious journals such as PLoS ONE, Biological Psychiatry and Human Molecular Genetics.

In The Last Decade

Ming‐Fen Ho

28 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming‐Fen Ho United States 13 93 81 68 50 42 32 325
Sarah K. Woody United States 6 92 1.0× 42 0.5× 23 0.3× 76 1.5× 41 1.0× 8 395
Eliana Cristina de Brito Toscano Brazil 9 119 1.3× 69 0.9× 17 0.3× 21 0.4× 52 1.2× 30 344
Harinder Singh United States 8 85 0.9× 79 1.0× 91 1.3× 9 0.2× 82 2.0× 23 294
Sanam Mustafa Australia 14 221 2.4× 34 0.4× 22 0.3× 13 0.3× 128 3.0× 28 444
A.F.Y. Al Hadithy Netherlands 9 64 0.7× 30 0.4× 22 0.3× 62 1.2× 68 1.6× 17 305
James D. Nicholson United States 13 160 1.7× 100 1.2× 24 0.4× 11 0.2× 49 1.2× 24 482
Danijela Laketa Serbia 12 95 1.0× 25 0.3× 12 0.2× 22 0.4× 37 0.9× 25 337

Countries citing papers authored by Ming‐Fen Ho

Since Specialization
Citations

This map shows the geographic impact of Ming‐Fen Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Fen Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Fen Ho more than expected).

Fields of papers citing papers by Ming‐Fen Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Fen Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Fen Ho. The network helps show where Ming‐Fen Ho may publish in the future.

Co-authorship network of co-authors of Ming‐Fen Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Ming‐Fen Ho. A scholar is included among the top collaborators of Ming‐Fen Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming‐Fen Ho. Ming‐Fen Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ho, Ming‐Fen, et al.. (2025). Psychedelic Treatments in Adolescent Psychopharmacology: Considering Safety, Ethics, and Scientific Rigor. Journal of Child and Adolescent Psychopharmacology. 35(3). 118–125. 5 indexed citations
2.
3.
Costa, Sabrina Corrêa da, Nicholas L. Bormann, Tyler Oesterle, et al.. (2025). The Role of Psychedelics in the Treatment of Substance Use Disorders: An Overview of Systematic Reviews. Brain Sciences. 15(10). 1056–1056.
4.
Ho, Ming‐Fen, Cheng Zhang, Brandon J. Coombes, et al.. (2024). IL17RB genetic variants are associated with acamprosate treatment response in patients with alcohol use disorder: A proteomics-informed genomics study. Brain Behavior and Immunity. 120. 304–314. 1 indexed citations
5.
Ho, Ming‐Fen, Cheng Zhang, Irene Moon, et al.. (2024). Molecular mechanisms involved in alcohol craving, IRF3, and endoplasmic reticulum stress: a multi-omics study. Translational Psychiatry. 14(1). 165–165. 2 indexed citations
6.
Ho, Ming‐Fen, Cheng Zhang, Irene Moon, et al.. (2023). Epigenetic regulation of GABA catabolism in iPSC-derived neurons: The molecular links between FGF21 and histone methylation. Molecular Metabolism. 77. 101798–101798. 5 indexed citations
7.
Sarangi, Vivekananda, Duan Liu, Ming‐Fen Ho, et al.. (2022). ACE2 and TMPRSS2 SARS-CoV-2 infectivity genes: deep mutational scanning and characterization of missense variants. Human Molecular Genetics. 31(24). 4183–4192. 9 indexed citations
8.
Ho, Ming‐Fen, Cheng Zhang, Irene Moon, et al.. (2022). Single cell transcriptomics reveals distinct transcriptional responses to oxycodone and buprenorphine by iPSC-derived brain organoids from patients with opioid use disorder. Molecular Psychiatry. 29(6). 1636–1646. 21 indexed citations
9.
Ho, Ming‐Fen, Cheng Zhang, Irene Moon, et al.. (2022). Plasma TNFSF10 levels associated with acamprosate treatment response in patients with alcohol use disorder. Frontiers in Pharmacology. 13. 986238–986238. 7 indexed citations
10.
Biernacka, Joanna M., Brandon J. Coombes, Anthony Batzler, et al.. (2021). Genetic contributions to alcohol use disorder treatment outcomes: a genome-wide pharmacogenomics study. Neuropsychopharmacology. 46(12). 2132–2139. 29 indexed citations
11.
Zhang, Lingxin, Vivekananda Sarangi, Ming‐Fen Ho, et al.. (2021). SLCO1B1: Application and Limitations of Deep Mutational Scanning for Genomic Missense Variant Function. Drug Metabolism and Disposition. 49(5). 395–404. 17 indexed citations
12.
Ho, Ming‐Fen, Cheng Zhang, Lingxin Zhang, et al.. (2020). TSPAN5 influences serotonin and kynurenine: pharmacogenomic mechanisms related to alcohol use disorder and acamprosate treatment response. Molecular Psychiatry. 26(7). 3122–3133. 19 indexed citations
13.
Ho, Ming‐Fen, Cheng Zhang, Lingxin Zhang, Hu Li, & Richard M. Weinshilboum. (2019). Ketamine and Active Ketamine Metabolites Regulate STAT3 and the Type I Interferon Pathway in Human Microglia: Molecular Mechanisms Linked to the Antidepressant Effects of Ketamine. Frontiers in Pharmacology. 10. 1302–1302. 33 indexed citations
14.
Moon, Irene, Ming‐Fen Ho, Nicholas B. Larson, et al.. (2019). Pharmacogenomic Next-Generation DNA Sequencing: Lessons from the Identification and Functional Characterization of Variants of Unknown Significance in CYP2C9 and CYP2C19. Drug Metabolism and Disposition. 47(4). 425–435. 16 indexed citations
15.
Ho, Ming‐Fen, Edroaldo Lummertz da Rocha, Cheng Zhang, et al.. (2018). TCL1A, a Novel Transcription Factor and a Coregulator of Nuclear Factor κB p65: Single Nucleotide Polymorphism and Estrogen Dependence. Journal of Pharmacology and Experimental Therapeutics. 365(3). 700–710. 7 indexed citations
16.
Ho, Ming‐Fen, Cristina Correia, James N. Ingle, et al.. (2018). Ketamine and ketamine metabolites as novel estrogen receptor ligands: Induction of cytochrome P450 and AMPA glutamate receptor gene expression. Biochemical Pharmacology. 152. 279–292. 37 indexed citations
17.
Liu, Duan, Ming‐Fen Ho, Daniel J. Schaid, et al.. (2017). Breast cancer chemoprevention pharmacogenomics: Deep sequencing and functional genomics of the ZNF423 and CTSO genes. npj Breast Cancer. 3(1). 30–30. 11 indexed citations
18.
19.
Ho, Ming‐Fen, et al.. (2016). Pharmacology of the Adenosine A3 Receptor in the Vasculature and Essential Hypertension. PLoS ONE. 11(2). e0150021–e0150021. 16 indexed citations
20.
Ho, Ming‐Fen & Roselyn B. Rose’Meyer. (2013). Vascular Adenosine Receptors; Potential Clinical Applications. Current Vascular Pharmacology. 11(3). 327–337. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah K. Woody Breakdown of academic impact, for papers by Eliana Cristina de Brito Toscano Breakdown of academic impact, for papers by Harinder Singh Breakdown of academic impact, for papers by Sanam Mustafa Breakdown of academic impact, for papers by A.F.Y. Al Hadithy Breakdown of academic impact, for papers by James D. Nicholson Breakdown of academic impact, for papers by Danijela Laketa
Rankless by CCL
2026